Published in Osteoporos Int on March 10, 2015
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med (2007) 18.27
Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA (1999) 11.23
Ten years' experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med (2004) 8.86
Bisphosphonates: the first 40 years. Bone (2011) 3.01
Long-term use of bisphosphonates in osteoporosis. J Clin Endocrinol Metab (2010) 2.70
Use of alendronate and risk of incident atrial fibrillation in women. Arch Intern Med (2008) 2.66
Bisphosphonates: mode of action and pharmacology. Pediatrics (2007) 2.25
A systematic review of validated methods for identifying atrial fibrillation using administrative data. Pharmacoepidemiol Drug Saf (2012) 2.17
Bisphosphonates for osteoporosis--where do we go from here? N Engl J Med (2012) 2.01
Alendronate and atrial fibrillation. N Engl J Med (2007) 2.00
Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday. Am J Med (2012) 1.80
Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation. Europace (2008) 1.68
Osteoporosis treatment and atrial fibrillation: alendronate versus raloxifene. Menopause (2010) 1.57
Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control study. BMJ (2008) 1.54
Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. Calcif Tissue Int (2011) 1.50
Prolonged bisphosphonate release after treatment in children. N Engl J Med (2007) 1.32
A computer program for incidence density sampling of controls in case-control studies nested within occupational cohort studies. Am J Epidemiol (1989) 1.28
Osteoporosis treatments and adverse events. Curr Opin Rheumatol (2009) 1.20
Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis. Ther Clin Risk Manag (2010) 1.12
The efficacy of bisphosphonates in the prevention of vertebral, hip, and nonvertebral-nonhip fractures in osteoporosis: a network meta-analysis. Semin Arthritis Rheum (2010) 1.04
Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosis. J Bone Miner Res (2009) 1.03
Atrial fibrillation in fracture patients treated with oral bisphosphonates. J Intern Med (2009) 1.03
Safety of bisphosphonates in the treatment of osteoporosis. Am J Med (2009) 1.02
Insights into onco-cardiology: atrial fibrillation in cancer. J Am Coll Cardiol (2013) 1.01
Relation of bisphosphonate therapies and risk of developing atrial fibrillation. Am J Cardiol (2009) 0.99
Review of the cardiovascular safety of zoledronic acid and other bisphosphonates for the treatment of osteoporosis. Clin Ther (2010) 0.95
Persistence with osteoporosis medication among newly-treated osteoporotic patients. J Bone Miner Metab (2013) 0.95
Risk of serious atrial fibrillation and stroke with use of bisphosphonates: evidence from a meta-analysis. Chest (2013) 0.89
Bisphosphonate adverse effects, lessons from large databases. Curr Opin Rheumatol (2010) 0.88
Risk of atrial fibrillation associated with use of bisphosphonates and other drugs against osteoporosis: a cohort study. Calcif Tissue Int (2010) 0.88
Long term bisphosphonate use in osteoporotic patients; a step forward, two steps back. J Pharm Pharm Sci (2012) 0.85
Alendronate affects calcium dynamics in cardiomyocytes in vitro. Vascul Pharmacol (2009) 0.83
Atrial fibrillation: is the prevalence rising? Europace (2010) 0.81
Oral mucosa produces cytokines and factors influencing osteoclast activity and endothelial cell proliferation, in patients with osteonecrosis of jaw after treatment with zoledronic acid. Clin Oral Investig (2012) 0.81
Use of bisphosphonate and risk of atrial fibrillation in older women with osteoporosis. Osteoporos Int (2011) 0.81
Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures. Osteoporos Int (2012) 0.80
Medical treatment of atrial fibrillation. J Cardiovasc Med (Hagerstown) (2012) 0.80
Atrial fibrillation and risk. Clin Cardiol (2012) 0.77
Alendronate regulates cytokine production induced by lipid A through nuclear factor-κB and Smad3 activation in human gingival fibroblasts. J Periodontal Res (2011) 0.76
Impact of treatment efficacy and dosing frequency on cost-effectiveness of bisphosphonate treatment for osteoporosis: a perspective. Curr Med Res Opin (2009) 0.76
Alcohol and coronary heart disease: a meta-analysis. Addiction (2000) 3.72
The Italian way of osteoporosis. Lancet (1992) 2.67
A meta-analysis of alcohol drinking and cancer risk. Br J Cancer (2001) 2.47
Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg (2004) 2.36
Survival and causes of death in Italian patients with ulcerative colitis. A GISC nationwide study. Dig Liver Dis (2001) 2.30
A case-control study of gastric cancer and diet in Italy. Int J Cancer (1989) 2.17
Alcohol drinking and cutaneous melanoma risk: a systematic review and dose-risk meta-analysis. Br J Dermatol (2014) 2.15
Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program. Hypertension (2000) 2.12
Light alcohol drinking and cancer: a meta-analysis. Ann Oncol (2012) 2.04
Glycemic control of older adults with type 2 diabetes: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Am Geriatr Soc (2000) 1.94
Exploring the dose-response relationship between alcohol consumption and the risk of several alcohol-related conditions: a meta-analysis. Addiction (1999) 1.90
Use of benzodiazepines in the Italian general population: prevalence, pattern of use and risk factors for use. Eur J Clin Pharmacol (1996) 1.86
Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. J Am Coll Cardiol (1999) 1.71
Protein microcrystals and the design of a microdiffractometer: current experience and plans at EMBL and ESRF/ID13. Acta Crystallogr D Biol Crystallogr (1999) 1.69
Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP). Acta Psychiatr Scand (2010) 1.67
Incidence of inflammatory bowel disease in Italy: a nationwide population-based study. Gruppo Italiano per lo Studio del Colon e del Retto (GISC) Int J Epidemiol (1996) 1.65
A meta-analysis on alcohol drinking and gastric cancer risk. Ann Oncol (2011) 1.62
Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP). J Hypertens (2000) 1.62
Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects. AIDS (2000) 1.60
Bone mass and metabolism in patients with celiac disease. Gastroenterology (1995) 1.59
A meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma risk. Ann Oncol (2011) 1.57
Assessing 5-year incidence rates and determinants of osteoporotic fractures in primary care. Bone (2011) 1.55
In-label and off-label use of respiratory drugs in the Italian paediatric population. Acta Paediatr (2010) 1.54
Epidemiology and prevention of oral cancer. Oral Oncol (1997) 1.53
Alcohol consumption and the risk of cancer: a meta-analysis. Alcohol Res Health (2001) 1.52
Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group. J Am Coll Cardiol (1999) 1.51
Risk of cancer onset in sub-Saharan Africans affected with chronic gastrointestinal parasitic diseases. Int J Immunopathol Pharmacol (2005) 1.50
High-throughput sample handling and data collection at synchrotrons: embedding the ESRF into the high-throughput gene-to-structure pipeline. Acta Crystallogr D Biol Crystallogr (2006) 1.50
Lack of adherence to lipid-lowering drug treatment. A comparison of utilization patterns in defined populations in Funen, Denmark and Bologna, Italy. Br J Clin Pharmacol (2000) 1.49
Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis. Dig Liver Dis (2005) 1.49
School-based prevention for illicit drugs' use. Cochrane Database Syst Rev (2005) 1.48
Allergic rhinitis in the Italian population evaluated through the national database of general practitioners. Allergy (2007) 1.48
Attributable risk for symptomatic liver cirrhosis in Italy. Collaborative Groups for the Study of Liver Diseases in Italy. J Hepatol (1998) 1.47
Does drinking pattern modify the effect of alcohol on the risk of coronary heart disease? Evidence from a meta-analysis. J Epidemiol Community Health (2008) 1.43
Family history and risk of stomach cancer in Italy. Cancer Epidemiol Biomarkers Prev (1994) 1.42
Information to cancer patients: a questionnaire survey in three different geographical areas in Italy. Support Care Cancer (2008) 1.41
"Crohn's disease activity index" is inaccurate to detect the post-operative recurrence in Crohn's disease. A GISC study. Gruppo Italiano per lo Studio del Colon e del Retto. Ital J Gastroenterol Hepatol (1999) 1.41
What do Italians at high risk of stroke know about ischaemic stroke? A survey among a group of subjects undergoing neuro-sonographic examination. Neurol Sci (2006) 1.41
Enhanced spasticity in primary progressive MS patients treated with interferon beta-1b. Neurology (1998) 1.40
Topical oropharyngeal vancomycin to control methicillin-resistant Staphylococcus aureus lower airway infection in ventilated patients. Minerva Anestesiol (2010) 1.40
Use of lipid-lowering drugs from 1990 to 1994: an international comparison among Australia, Finland, Italy (Emilia Romagna Region), Norway and Sweden. Eur J Clin Pharmacol (1997) 1.33
Epidemiological profile of symptomatic osteoarthritis in older adults: a population based study in Dicomano, Italy. Ann Rheum Dis (2003) 1.32
A case-control study of gastric cancer and diet in Italy: II. Association with nutrients. Int J Cancer (1990) 1.32
Short-chain fatty acid topical treatment in distal ulcerative colitis. Aliment Pharmacol Ther (1995) 1.29
Medicines for children licensed by the European Medicines Agency (EMEA): the balance after 10 years. Eur J Clin Pharmacol (2006) 1.29
Selective decontamination of the digestive tract reduces bacterial bloodstream infection and mortality in critically ill patients. Systematic review of randomized, controlled trials. J Hosp Infect (2007) 1.28
Neutron Laue diffractometry with an imaging plate provides an effective data collection regime for neutron protein crystallography. Nat Struct Biol (1997) 1.24
The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database. Acta Diabetol (2011) 1.23
Interactions between triazoles and amphotericin B against Cryptococcus neoformans. Antimicrob Agents Chemother (2000) 1.23
Undetected burden of tuberculosis in a low-prevalence area. Int J Tuberc Lung Dis (2006) 1.22
Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Aliment Pharmacol Ther (1994) 1.22
Intestinal permeability test as a predictor of clinical course in Crohn's disease. Am J Gastroenterol (1999) 1.22
Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus. Diabetologia (2006) 1.19
Coffee, caffeine, and the risk of liver cirrhosis. Ann Epidemiol (2001) 1.17
Reproductive history and gastric cancer among post-menopausal women. Int J Cancer (1994) 1.16
Type 2 diabetes in older well-functioning people: who is undiagnosed? Data from the Health, Aging, and Body Composition study. Diabetes Care (2001) 1.16
Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection. Addict Behav (2011) 1.15
Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma. Ann Surg Oncol (2009) 1.14
Reproducibility of histologic classification of gastric cancer. Br J Cancer (1991) 1.13
Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: an ominous prognostic sign. J Am Coll Cardiol (1997) 1.11
17Beta-oestradiol reduces cardiac leukocyte accumulation in myocardial ischaemia reperfusion injury in rat. Eur J Pharmacol (1997) 1.10
Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how? J Intern Med (2014) 1.09
The spasticity evaluation test (SeT): a pilot study. J Rehabil Res Dev (2001) 1.09
The cost of atopic dermatitis in the Netherlands: an international comparison. Br J Dermatol (2002) 1.08
Gastric cancer in a high-risk area in Italy. Histopathologic patterns according to Lauren's classification. Cancer (1988) 1.07
An innovative hand brace for carpal tunnel syndrome: a randomized controlled trial. Muscle Nerve (2001) 1.06
Concentrations of nitrates in drinking water and incidence of gastric carcinomas: first descriptive study of the Piemonte Region, Italy. Sci Total Environ (1984) 1.06
A case-control study of gastric cancer and diet in Italy. III. Risk patterns by histologic type. Int J Cancer (1991) 1.06
Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: comparison with Child-Pugh score and serum bile acid levels. World J Gastroenterol (2005) 1.05
Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation. Ann Oncol (2007) 1.05
Foreign body inhalation in children: an update. Acta Otorhinolaryngol Ital (2010) 1.03
The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity. J Clin Endocrinol Metab (2001) 1.02
Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group. Br Heart J (1994) 1.02
Gender assessment through three-dimensional analysis of maxillary sinuses by means of cone beam computed tomography. Eur Rev Med Pharmacol Sci (2015) 1.01
Meta-analysis of alcohol intake in relation to risk of liver cirrhosis. Alcohol Alcohol (1998) 1.01
Trends of liver cirrhosis mortality in Europe, 1970-1989: age-period-cohort analysis and changing alcohol consumption. Int J Epidemiol (1997) 1.01
Paraoxonase genotypes, lipoprotein lipase activity, and HDL. Arterioscler Thromb Vasc Biol (1996) 1.01
Is suboptimal prescribing a risk factor for poor health outcomes in community-dwelling elders? The ICARe Dicomano study. Pharmacoepidemiol Drug Saf (2010) 1.00
Alcohol drinking and risk of renal cell carcinoma: results of a meta-analysis. Ann Oncol (2012) 0.99
Lymphadenectomy in gastric cancer: influence on prognosis of lymph node count. J Exp Clin Cancer Res (2004) 0.99
Maximum gastric cancer diameter as a prognostic indicator: univariate and multivariate analysis. J Exp Clin Cancer Res (2003) 0.99
The prescribing of analgesics and non-steroidal anti-inflammatory drugs in paediatric primary care in the UK, Italy and the Netherlands. Pharmacol Res (2010) 0.98
Loss of Dp140 dystrophin isoform and intellectual impairment in Duchenne dystrophy. Neurology (2000) 0.98
Early childhood caries underweight or overweight, that is the question. Eur J Paediatr Dent (2011) 0.98
Endolaparoscopic rendezvous treatment: a satisfying therapeutic choice for cholecystocholedocolithiasis. Surg Endosc (2001) 0.98
Safety of interferon beta treatment for chronic HCV hepatitis. World J Gastroenterol (2004) 0.98
Sensory nerves affect the recruitment and differentiation of rat periovarian brown adipocytes during cold acclimation. J Cell Sci (1998) 0.97
Prion protein glycotype analysis in familial and sporadic Creutzfeldt-Jakob disease patients. Brain Res Bull (1999) 0.97
Prescribing patterns of antiepileptic drugs in Italy: a nationwide population-based study in the years 2000-2005. Eur J Neurol (2007) 0.97
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women. Arterioscler Thromb Vasc Biol (2001) 0.96
Predictors of change in alcohol consumption among Frenchmen of the GAZEL study cohort. Addiction (1999) 0.96
Occupational exposures as risk factors for gastric cancer in Italy. Cancer Causes Control (1994) 0.95
Calcium metabolism in adolescents and young adults with type 1 diabetes mellitus without and with persistent microalbuminuria. J Endocrinol Invest (1999) 0.95
Two-dimensional vs. two- plus four-dimensional ultrasound in pregnancy and the effect on maternal emotional status: a randomized study. Ultrasound Obstet Gynecol (2005) 0.95
Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study. Pharmacoepidemiol Drug Saf (2007) 0.94
Efficacy of a soft hand brace and a wrist splint for carpal tunnel syndrome: a randomized controlled study. Acta Neurol Scand (2008) 0.94